Thank you, Yonah. Good morning, everyone, and thank you for joining us. In the fourth quarter, we once again demonstrated that the diversity of our offerings and the strength of our go-to-market operations can deliver profitable results. We achieved these results in what has continued to be a CapEx constrained environment for our customers and a challenging chapter for our industry. I am particularly pleased to report that we delivered another record quarter of consumables revenue, a testament to strong usage of our systems. We also achieved our 10th consecutive quarter of profitability on an adjusted basis, which reflects the discipline of our business model that differentiates us in our sector. Stratasys is laying the foundation for meaningful use cases that will significantly contribute to our financial performance. Our suite of offerings features best-in-class technologies that allow our customers to advance the use of additive manufacturing and increasingly broaden applications into manufacturing at scale. As our Neo branding states, we make additive work for our customers, and we see that playing out every day, whether it is the strong utilization of systems they purchased from us in the past, or in the continued high level of engagement we see today for Neo systems, incorporating cutting-edge technologies. As the macro business environment continues to improve and capital spending patterns return to normal, we expect the pent-up demand to re-accelerate growth, particularly in our system sales. We delivered solid revenues in 2023 of $628 million, down 3.7% versus 2022, but up 1.3% after excluding the MakerBot divestiture and the two businesses we divested from our Stratasys Direct Service Bureau, showing remarkable resilience against a severely CapEx constrained environment for our customers. We improved our gross margin for the year, despite the modest change in revenues, reflecting our focus on cost controls and operating efficiencies, and we delivered $0.11 in adjusted EPS in 2023. We are confident that as our Neo technologies ramp and our operational efficiencies continue, gross margins and profitability will strengthen in 2024 and beyond. We continue to maintain a healthy balance sheet that provides stability through challenging times, and optionality to support our growth through both organic investment and accretive acquisition opportunities. And as we shared each year, in 2023 we generated 34% of our revenues from manufacturing, up from 32.5% in 2022. We expect to see this metric grow stronger as global business conditions improve, to a point where the majority of our business will come from end-part manufacturing at scale. Now, let me touch on some of our success stories for the quarter, starting with our industrial business. 35 years ago, our Founder, Scott Crump, invented FDM 3D Printing, which remains by far the industry most popular technology. Since its introduction, Stratasys has consistently been the leader for industrial FDM manufacturing. And in the fourth quarter, we brought another major technology innovation to market with the F3300 printer. Our first FDM Printer on a platform designed to support scalable production. The F3300 doubled the speed of existing technology with greater reliability and operating efficiency, while being geared toward manufacturing at higher volumes. We worked closely with our customers for several years to deliver this Neo system and are proud that Toyota is our first customer. The F3300 can be used for production of parts, fixtures and prototyping applications to help bring Neo products to market faster. Our F3300 pipeline is strong, with accelerating interest and engagement levels, and we look forward to sharing more customer wins. Also in automotive, we recently launched an initiative to help Daimler Truck North America, produce more manufacturing support parts and functional prototypes by adding our H350 system, paired with GrabCAD Print Pro, to their existing portfolio of Stratasys printers. Daimler expects to see significant improvement in their prototyping and a shift to manufacturing starting this year. Our Neo line of Stereolithography printers had a strong finish to the year, including orders from Whirlpool and multiple service bureau in the U.S. and Europe. And already in 2024, PartsToGo, a German service bureau, that had two Neo printers, purchased four more systems, enabling them to produce high quality, accurate and repeatable parts for their customers' industrial level application needs. We also made further inroads in the Formula One racing community, with multi-unit sales of Neo SLA systems to Toyota, F1 McLaren and other industry leaders for use in wind tunnel testing and tooling. This is particularly promising and that it demonstrates our technology's ability to deliver accuracy, consistency and reliability at the highest level of automotive standards. We expect this will result in transferability to mainstream automotive manufacturing. While the Neo system is exciting for its use in prototyping and tooling today, the real competitive advantage will come with the next version expected in 2025, which will shift the focus of that technology to end part manufacturing. Further on in automotive, we increased our exposure to automotive interior design with our PolyJet technology through collaboration with Mercedes-Benz, Maserati, Volkswagen and Stellantis. All-in-all, we are on the path for what we believe will be serial production use cases for the automotive industry. Next, I'd like to provide some highlights on our dental applications and key milestones. Dental continues to be one of the largest and most exciting growth avenues for the 3D printing industry, and for Stratasys in particular. As a reminder, our activities are focused on dentures and other non-discretionary restorative spending. In 2023, dental continued to grow, and we expect this trend to accelerate. This growth came two ways. First, we further extended our customer's base with new products offerings to address a broader range of applications in a more economically beneficial way. Including dentures, implant models, surgical guides and other parts used in fixed restoration cases. Our TrueDent solution rolled out during the first quarter of 2023 is a great example of how customers can use 3D printing to replace conventional manufacturing technologies. Pairing TrueDent resins and workflows with our J5 DentaJet printers allow the creation of a full permanent monolithic dentures. No other technology in the world is able to provide this at scale. This pairing also enable us to lower production costs and labor for labs by more than 50%, while improving form, fit, and function for the patient. Leading labs networks, and dental support organizations, or DSOs, in the U.S. and Europe, who are new customers for Stratasys, have begun deploying this offering to better serve their patients, and have provided us with excellent feedback on clinical outcome and patient satisfaction. As a real life example of just how disruptive and impactful TrueDent is, last month we announced our partnership with Express Dental of Oklahoma, at a two day event where dental services are provided for free to those in need. Over 55 people had their mouth scanned on the first day, and the very next day went home with a brand new set of dentures, courtesy of TrueDent. This level of speed, accuracy, and low cost has never been possible at scale until today. We plan to roll out new business models and partnerships to accelerate adoption of additive manufacturing in dentistry, and expect this business to meaningfully accelerate in the years to come as we continue to win business from conventional manufacturing. And second, we delivered growth in dental to our existing customers, extending their fleet and increasing utilization of our resins on our newest platform. This was a significant contribution to our revenue growth in consumable in 2023. Now switching to medical, where some of the most exciting opportunities for future growth are being developed. During the quarter, we announced a partnership with Siemens Healthineers to carry out a landmark research project. This project is designed to develop new state-of-the-art solutions for the advancement of medical imaging phantoms for computed tomography imaging. These are used around the world to evaluate and ensure optimal performance of CT scanners. We also announced that the University Hospital Birmingham in England has been using tailored 3D printing cutting guides to improve surgical outcomes for head and neck cancer patients, produced exclusively using our J5MediJet printer. This success demonstrates that our technology enables the creation of vital, highly accurate, patient-specific cutting guides ahead of surgical procedures. And I would be remiss if I didn't express my pride in Stratasys winning the Medical, Dental or Healthcare Application Category at the Prestige 3D Printing Industry Awards in London in December, where our J5 DentaJet, J5MediJet and J850 Digital Anatomy Printers beat out a field of nine competitors. Turning to software, we have a long-term plan to monetize our software offering and create new streams of recurring revenue by adding value through new features and products to our free GrabCAD platform, both for use with our own systems and for those who partner with us. In 2023, we demonstrated early success in our channel's ability to sell software alongside Neo printers. A major attribute for the Neo software, its ability to help service bureaus and internal 3D print shops rapidly and accurately estimate the cost and time of printed parts. And we have intensified our effort to expand a subscription software business with the Pro version of our popular GrabCAD software. GrabCAD Print is used by over 85% of our customers and over 40,000 users worldwide. GrabCAD Print Pro is targeted at helping users achieve 3D printing that is faster, more accurate, and more economical, with the ability to print multiple parts for multiple customers on multiple printers simultaneously. GrabCAD Print Pro is currently available on FDM and SAF systems. And a few days ago, we announced we are now in the process of adding it to PolyJet. We expect to support it across our full suite of technology offerings once we add it to the P3 and Neo in the future. And turning to new materials, we have recently announced our Origin One DLP system, which is building a leading position for production of manufacturing aids, particularly in the automotive industry. We recently introduced our new Somos WeatherX 100 material. This is our first material using SAE automotive industry standards that is tested for weatherability, UV durability, and dimensional accuracy. With the introduction of this, an additional material during 2024, we plan to strengthen our position in DLP and open more manufacturing use cases. Before I turn the call over to our CFO, Eitan